Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer: A Randomized Clinical Trial
晚期乳腺癌一线与二线 CDK4/6 抑制剂治疗的总生存期：一项随机临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2025.6585
Wortelboer, Noor; van Ommen-Nijhof, Annemiek; Konings, Inge R; van der Noort, Vincent; van den Pol, Esther; Guerrero Páez, Cristina; Bakker, Sandra D; Hovenga, Sjoerd; Imholz, Alex L T; Kamm, Yvonne J L; van Leeuwen, Lobke; Luykx-de Bakker, Sylvia A; Mandigers, Caroline M P W; van Riel, Johanna M G H; Tol, Jolien; van de Wouw, Agnes J; Wilting, Saskia M; van Leeuwen-Stok, A Elise; Jager, Agnes; Sonke, Gabe S
